Coldstream Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.08M | Sell |
24,021
-39,451
| -62% | -$3.78M | 0.03% | 294 |
|
|
2025
Q4 | $6.1M | Sell |
63,472
-1,679
| -3% | -$163K | 0.08% | 135 |
|
|
2025
Q3 | $6.21M | Buy |
65,151
+12,694
| +24% | +$1.17M | 0.08% | 130 |
|
|
2025
Q2 | $4.57M | Buy |
52,457
+2,070
| +4% | +$176K | 0.07% | 151 |
|
|
2025
Q1 | $4.53M | Buy |
50,387
+36,757
| +270% | +$3.29M | 0.1% | 128 |
|
|
2024
Q4 | $1.09M | Sell |
13,630
-692
| -5% | -$59.9K | 0.02% | 361 |
|
|
2024
Q3 | $1.29M | Buy |
14,322
+2,610
| +22% | +$220K | 0.03% | 312 |
|
|
2024
Q2 | $922K | Sell |
11,712
-343
| -3% | -$28.1K | 0.02% | 345 |
|
|
2024
Q1 | $1.05M | Buy |
12,055
+2,945
| +32% | +$251K | 0.03% | 315 |
|
|
2023
Q4 | $750K | Sell |
9,110
-3,182
| -26% | -$243K | 0.02% | 366 |
|
|
2023
Q3 | $963K | Buy |
12,292
+24
| +0.2% | +$2.01K | 0.03% | 267 |
|
|
2023
Q2 | $1.08M | Buy |
12,268
+222
| +2% | +$19.1K | 0.03% | 258 |
|
|
2023
Q1 | $971K | Buy |
12,046
+4,264
| +55% | +$348K | 0.03% | 278 |
|
|
2022
Q4 | $605K | Buy |
+7,782
| New | +$631K | 0.02% | 368 |
|
|
2022
Q2 | $794K | Sell |
8,852
-2,715
| -23% | -$275K | 0.03% | 269 |
|
|
2022
Q1 | $1.28M | Sell |
11,567
-24,897
| -68% | -$2.63M | 0.04% | 213 |
|
|
2021
Q4 | $3.77M | Buy |
36,464
+6,000
| +20% | +$695K | 0.12% | 112 |
|
|
2021
Q3 | $3.17M | Sell |
30,464
-2,988
| -9% | -$387K | 0.15% | 92 |
|
|
2021
Q2 | $4.15M | Buy |
33,452
+1,688
| +5% | +$212K | 0.17% | 91 |
|
|
2021
Q1 | $3.75M | Sell |
31,764
-1,003
| -3% | -$118K | 0.22% | 73 |
|
|
2020
Q4 | $3.84M | Buy |
32,767
+4,180
| +15% | +$460K | 0.23% | 68 |
|
|
2020
Q3 | $2.97M | Buy |
28,587
+626
| +2% | +$62.9K | 0.25% | 65 |
|
|
2020
Q2 | $2.56M | Buy |
27,961
+25,422
| +1,001% | +$2.44M | 0.23% | 74 |
|
|
2020
Q1 | $229K | Sell |
2,539
-808
| -24% | -$86K | 0.03% | 237 |
|
|
2019
Q4 | $380K | Buy |
3,347
+654
| +24% | +$71.8K | 0.03% | 233 |
|
|
2019
Q3 | $292K | Buy |
2,693
+170
| +7% | +$17.7K | 0.02% | 249 |
|
|
2019
Q2 | $245K | Buy |
2,523
+209
| +9% | +$19.1K | 0.02% | 274 |
|
|
2019
Q1 | $211K | Sell |
2,314
-1,331
| -37% | -$119K | 0.02% | 288 |
|
|
2018
Q4 | $332K | Buy |
3,645
+1,383
| +61% | +$129K | 0.03% | 229 |
|
|
2018
Q3 | $222K | Buy |
+2,262
| New | +$209K | 0.02% | 330 |
|
|
2016
Q4 | – | Sell |
-21,767
| Closed | -$1.88M | – | 249 |
|
|
2016
Q3 | $1.88M | Buy |
+21,767
| New | +$1.9M | 0.33% | 57 |
|
|
2016
Q1 | – | Sell |
-35,192
| Closed | -$2.71M | – | 281 |
|
|
2015
Q4 | $2.71M | Sell |
35,192
-131
| -0.4% | -$9.86K | 0.59% | 25 |
|
|
2015
Q3 | $2.36M | Sell |
35,323
-1,871
| -5% | -$138K | 0.63% | 29 |
|
|
2015
Q2 | $2.76M | Sell |
37,194
-3,409
| -8% | -$260K | 0.72% | 25 |
|
|
2015
Q1 | $3.17M | Buy |
40,603
+498
| +1% | +$37.7K | 0.87% | 21 |
|
|
2014
Q4 | $2.9M | Sell |
40,105
-105
| -0.3% | -$7.29K | 0.81% | 20 |
|
|
2014
Q3 | $2.49M | Buy |
40,210
+702
| +2% | +$44.6K | 0.71% | 26 |
|
|
2014
Q2 | $2.52M | Buy |
39,508
+752
| +2% | +$45.7K | 0.74% | 23 |
|
|
2014
Q1 | $2.38M | Buy |
38,756
+102
| +0.3% | +$5.94K | 0.77% | 20 |
|
|
2013
Q4 | $2.22M | Sell |
38,654
-408
| -1% | -$23.1K | 0.71% | 24 |
|
|
2013
Q3 | $2.08M | Buy |
39,062
+292
| +0.8% | +$15.7K | 0.68% | 30 |
|
|
2013
Q2 | $2M | Buy |
+38,770
| New | +$1.92M | 0.67% | 28 |
|
Other funds holding MDT
VCM
VPM
Coldstream Capital Management's MDT Position: Q1 2026 in Review
Coldstream Capital Management reduced its Medtronic (MDT) stake by 62% in Q1 2026, selling an estimated $3.78M and leaving 24,021 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #294.
Coldstream Capital Management first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $6.21M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Coldstream Capital Management held 24,021 shares of Medtronic worth $2.08M as of Q1 2026.
- Coldstream Capital Management sold 39,451 Medtronic shares in Q1 2026, an estimated $3.78M.
- Medtronic made up 0.03% of Coldstream Capital Management's portfolio in Q1 2026, its #294 holding.
- Coldstream Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
- Coldstream Capital Management's Medtronic position peaked at $6.21M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.